Perrigo Co PLC (PRGO)
26.94
+0.12
(+0.47%)
USD |
NYSE |
Nov 14, 16:00
26.94
0.00 (0.00%)
After-Hours: 18:45
Perrigo Enterprise Value: 6.949B for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 6.949B |
| November 12, 2024 | 6.889B |
| November 11, 2024 | 6.936B |
| November 08, 2024 | 6.887B |
| November 07, 2024 | 6.965B |
| November 06, 2024 | 7.017B |
| November 05, 2024 | 6.749B |
| November 04, 2024 | 6.758B |
| November 01, 2024 | 6.852B |
| October 31, 2024 | 6.789B |
| October 30, 2024 | 6.762B |
| October 29, 2024 | 6.892B |
| October 28, 2024 | 6.809B |
| October 25, 2024 | 6.716B |
| October 24, 2024 | 6.714B |
| October 23, 2024 | 6.757B |
| October 22, 2024 | 6.815B |
| October 21, 2024 | 6.819B |
| October 18, 2024 | 6.744B |
| October 17, 2024 | 6.701B |
| October 16, 2024 | 6.620B |
| October 15, 2024 | 6.608B |
| October 14, 2024 | 6.591B |
| October 11, 2024 | 6.617B |
| October 10, 2024 | 6.601B |
| Date | Value |
|---|---|
| October 09, 2024 | 6.615B |
| October 08, 2024 | 6.630B |
| October 07, 2024 | 6.617B |
| October 04, 2024 | 6.694B |
| October 03, 2024 | 6.669B |
| October 02, 2024 | 6.714B |
| October 01, 2024 | 6.766B |
| September 30, 2024 | 6.871B |
| September 27, 2024 | 7.019B |
| September 26, 2024 | 7.016B |
| September 25, 2024 | 7.005B |
| September 24, 2024 | 7.140B |
| September 23, 2024 | 7.211B |
| September 20, 2024 | 7.220B |
| September 19, 2024 | 7.308B |
| September 18, 2024 | 7.361B |
| September 17, 2024 | 7.342B |
| September 16, 2024 | 7.368B |
| September 13, 2024 | 7.305B |
| September 12, 2024 | 7.222B |
| September 11, 2024 | 7.166B |
| September 10, 2024 | 7.223B |
| September 09, 2024 | 7.151B |
| September 06, 2024 | 7.297B |
| September 05, 2024 | 7.364B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.882B
Minimum
May 09 2022
11.29B
Maximum
Feb 25 2020
8.357B
Average
8.414B
Median
Jan 12 2023
Enterprise Value Benchmarks
| Alkermes PLC | 4.111B |
| Biogen Inc | 28.75B |
| Jazz Pharmaceuticals PLC | 11.21B |
| Medtronic PLC | 133.01B |
| Iterum Therapeutics PLC | 25.30M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.00M |
| Revenue (Quarterly) | 1.088B |
| Total Expenses (Quarterly) | 974.10M |
| EPS Diluted (Quarterly) | -0.15 |
| Gross Profit Margin (Quarterly) | 37.19% |
| Profit Margin (Quarterly) | -1.93% |
| Earnings Yield | -4.34% |
| Operating Earnings Yield | 6.45% |
| Normalized Earnings Yield | 1.538 |